• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Patients enjoy near-vision plus of pseudoaccommodative IOL


Munich, Germany-The AcrySof ReSTOR pseudoaccommodative IOL (Alcon) with its apodized diffractive optic provides patients with excellent near visual acuity without compromising distance vision, signifi- cantly reducing contrast sensitivity, or increasing the incidence of severe visual disturbances compared with monofocal con- trols, said James A. Davison, MD, FACS, at the XXI Congress of the European Society of Cataract and Refractive Surgeons here.

Related Videos
EyeCon 2024: Peter J. McDonnell, MD, marvels on mentoring, modern technology, and ophthalmology’s future
Lorraine Provencher, MD, presenting slides
Katherine Talcott, MD, presenting slides
Katherine Talcott, MD, presenting slides
© 2024 MJH Life Sciences

All rights reserved.